KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Edwards Lifesciences (EW) Research & Development (2016 - 2025)

Edwards Lifesciences has reported Research & Development over the past 17 years, most recently at $267.7 million for Q4 2025.

  • Quarterly results put Research & Development at $267.7 million for Q4 2025, down 1.25% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 2.49% YoY), and the annual figure for FY2025 was $1.1 billion, up 2.49%.
  • Research & Development for Q4 2025 was $267.7 million at Edwards Lifesciences, down from $280.7 million in the prior quarter.
  • Over the last five years, Research & Development for EW hit a ceiling of $280.7 million in Q3 2025 and a floor of $130.6 million in Q4 2022.
  • Median Research & Development over the past 5 years was $250.8 million (2022), compared with a mean of $244.0 million.
  • Peak annual rise in Research & Development hit 85.38% in 2023, while the deepest fall reached 2.83% in 2023.
  • Edwards Lifesciences' Research & Development stood at $238.0 million in 2021, then crashed by 45.13% to $130.6 million in 2022, then surged by 85.38% to $242.1 million in 2023, then grew by 11.98% to $271.1 million in 2024, then fell by 1.25% to $267.7 million in 2025.
  • The last three reported values for Research & Development were $267.7 million (Q4 2025), $280.7 million (Q3 2025), and $276.2 million (Q2 2025) per Business Quant data.